AvKARE: Drug Recall
Recall #D-0460-2025 · 05/13/2025
Class II: Risk
Recall Details
- Recall Number
- D-0460-2025
- Classification
- Class II
- Product Type
- Drug
- Recalling Firm
- AvKARE
- Status
- Ongoing
- Date Initiated
- 05/13/2025
- Location
- Pulaski, TN, United States
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 3,817 50-count cartons
Reason for Recall
Presence of Foreign Tablets/Capsules: manufacturer recalled because one tadalafil 5mg tablet was found in 500 count bottle of Celecoxib 200 mg capsules
Product Description
Celecoxib Capsules, 200 mg, 50 Capsules (5x10) Unit Dose per carton, Rx Only, Manufactured for: AvKARE, Pulaski, TN 38478. NDC 50268-169-15
Distribution Pattern
Nationwide in the USA
Other Recalls by AvKARE
- Class II: Risk 12/31/2025
- Class II: Risk 09/02/2025
- Class II: Risk 08/25/2025
- Class II: Risk 08/25/2025
- Class III: Low Risk 06/26/2025
Data from FDA openFDA enforcement reports. This site is not affiliated with or endorsed by the FDA. Recall information may be updated by the FDA at any time.